Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amcare is a leading high-end healthcare service provider in China, primarily focused on women's and children's medical needs. Founded in 2006, the company operates a network of specialized hospitals and clinics providing services in obstetrics, gynecology, pediatrics, and assisted reproductive technology (ART). Amcare distinguishes itself through its adherence to international medical standards and a patient-centric service model, being the first private hospital group in China to achieve JCI accreditation. In August 2022, the company was fully acquired by ByteDance's healthcare subsidiary, Xiaohe Health, for approximately $1.5 billion. This acquisition represents a major expansion of ByteDance's footprint into the physical healthcare and hospital management sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amcare Hospital.